Showing results (151-160 of 349) with videos related to
Sort By:
Pageof 35
Psychopharmacology|January 1, 1983
The effects of chronic morphine treatment on neurotensin-induced antinociceptionD Luttinger, S K Burgess, C B Nemeroff, et al.The American Journal of Psychiatry|July 1, 1997
CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorderR P Sharma, P G Janicak, G Bissette, et al.Biological Psychiatry|December 18, 2001
The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugsE B Binder, B Kinkead, M J Owens, et al.Regulatory Peptides|April 1, 1989
Neuropeptides in Alzheimer's disease: a postmortem studyC B Nemeroff, J S Kizer, G P Reynolds, et al.Brain Research. Molecular Brain Research|February 1, 1992
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatumB Levant, K M Merchant, D M Dorsa, et al.Critical Reviews in Neurobiology|January 1, 1992
A commentary on methods in peptide neurobiology: focus on neurotensinS T Cain, G Bissette, C D Kilts, et al.The Journal of Comparative Neurology|September 20, 1982
Neurotensin: topographical distribution of brain sites involved in hypothermia and antinociceptionP W Kalivas, L Jennes, C B Nemeroff, et al.European Journal of Pharmacology|October 22, 1982
The effect of intracisternally administered bombesin on cysteamine-induced duodenal ulcers in ratsD E Hernandez, J W Adcock, C B Nemeroff, et al.Brain Research|February 11, 1985
Microinjection of neurotensin into the ventral tegmental area produces hypothermia: evaluation of dopaminergic mediationP W Kalivas, C B Nemeroff, J S Miller, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the ratM J Owens, C A Ballenger, D L Knight, et al.Pageof 35